
Greenwich, CT • Invite-Only
Request Invitation
$50M Clinical Trials Domain Monopoly
Bids are already circulating • Limited seats for qualified pharma, CROs, and investors
Registries
Sponsored Trials
Publishing
Pharma Finance
Why this matters now
- Controls the language of clinical trials transparency across registries, sponsors, media, and finance.
- Defensive urgency: prevents rivals from operating official-sounding portals that could confuse patients.
- Press risk: once mainstream coverage hits, boardrooms will be forced to react.
- Structured for bundle sale or selective acquisition under NDA.
Portfolio Highlights
ClinicalTrialsRegistry.com
NationalClinicalTrialsRegistry.com
SponsoredTrials.com
PharmaSponsoredTrials.com
PharmStocks.com
PharmStocks.org
GlobalClinicalTrialsRegistry.com
GlobalPharmaTrials.com
GlobalPharmaRegistry.com
Full inventory available upon request and NDA.
Market Activity
- Multiple qualified buyers have submitted pre-auction interest.
- Boardroom briefings underway across pharma and CROs.
- Invitation requests reviewed in order received; admission is limited.
Request Invitation
We prioritize board-authorized buyers given active bidding. Fields marked * are required.